Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines

Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19), which has reached pandemic proportions. A number of effective vaccines have been produced, including mRNA vaccines and viral vector vaccines, which are now being implemented on a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijkers, Ger T., Weterings, Nynke, Obregon-Henao, Andres, Lepolder, Michaëla, Dutt, Taru S., van Overveld, Frans J., Henao-Tamayo, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402319/
https://www.ncbi.nlm.nih.gov/pubmed/34451973
http://dx.doi.org/10.3390/vaccines9080848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402319/
https://www.ncbi.nlm.nih.gov/pubmed/34451973
http://dx.doi.org/10.3390/vaccines9080848

Ejemplares similares